MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

J&J, Boston Scientific Break Even in Patent Disputes

A federal judge has upheld two separate jury verdicts involving stent patents. One found Johnson & Johnson in violation of a Boston Scientific patent, and one found Boston Scientific in violation of a J&J patent, the Associated Press reports. J&J is appealing the ruling against it, which means it will probably be a while before compensation or damages payments are decided.

Much is at stake here, as J&J's Cypher and Boston Scientific's Taxus drug-eluting stents are the best-selling medical devices on the market.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish